Answers are grounded in this paper and cite their sources.
In this post hoc analysis of 82 patients initiating defibrotide within 30 days of starting chemotherapy, Kaplan-Meier estimated survival was 74.1% at 70 days after defibrotide initiation. Safety profile was consistent with prior defibrotide studies.
No takes yet. Share an insight, caveat, or question.
Kernan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: